PURE Bioscience (PURE)
(Delayed Data from OTC)
$0.08 USD
-0.01 (-9.90%)
Updated May 30, 2024 09:30 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
PURE Bioscience [PURE]
Reports for Purchase
Showing records 41 - 47 ( 47 total )
Company: PURE Bioscience
Industry: Medical - Products
A grass-roots campaign is under way through an alliance with the PTA.
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: PURE Bioscience
Industry: Medical - Products
HEALTHCARE -- SUSPENDING COVERAGE : Due to analyst departure.
Provider: C.K. Cooper and Company
Analyst: COHEN J
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
ValuEngine Detailed Valuation Report for PURE
Provider: VALUENGINE, INC
Company: PURE Bioscience
Industry: Medical - Products
We are initiating coverage of PURE Bioscience with a BUY rating and a target price of $1.75
Provider: C.K. Cooper and Company
Analyst: COHEN J
Company: PURE Bioscience
Industry: Medical - Products
We reiterate our BUY recommendation and set a 12-month target price of $5.25.
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: PURE Bioscience
Industry: Medical - Products
We reiterate our BUY recommendation and our target price of $9.00 per share
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K